Literature DB >> 1310747

Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma.

T Le Chevalier, R Arriagada, M Tarayre, M J Lacombe-Terrier, A Laplanche, E Quoix, P Ruffie, M Martin, J Y Douillard.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1310747     DOI： 10.1093/jnci/84.1.58

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  27 in total

1.  Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Authors:  Arya Amini; Jinzhong Yang; Ryan Williamson; Michelle L McBurney; Jeremy Erasmus; Pamela K Allen; Mandar Karhade; Ritsuko Komaki; Zhongxing Liao; Daniel Gomez; James Cox; Lei Dong; James Welsh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

2.  Evidence based radiation oncology with existing technology.

Authors:  Nicolas Isa
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-14

3.  Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.

Authors:  Masashi Kobayashi; Kaoru Matsui; Tomonori Hirashima; Takashi Nitta; Shinji Sasada; Takuhito Tada; Kazuo Minakuchi; Mitsugi Furukawa; Yoshitaka Ogata; Ichiro Kawase
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 4.  Is the use of chemotherapy justified in non-small-cell lung cancer?

Authors:  P Kelly; L Clancy
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

Review 5.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Authors:  Julian R Molina; Ping Yang; Stephen D Cassivi; Steven E Schild; Alex A Adjei
Journal:  Mayo Clin Proc       Date:  2008-05       Impact factor: 7.616

Review 6.  Adjuvant chemotherapy following radical cystectomy.

Authors:  C N Sternberg
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Phase I Study to Determine MTD of Docetaxel and Cisplatin with Concurrent Radiation Therapy for Stage III Non-Small Cell Lung Cancer.

Authors:  You-Quan Li; An-Hui Shi; Fu-Hai Li; Rong Yu; Guang-Ying Zhu
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

Review 8.  Current options in the treatment of non-small cell lung cancer.

Authors:  D Faulds
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  Lung cancer: a review of current therapeutic modalities.

Authors:  A B Sandler; A C Buzaid
Journal:  Lung       Date:  1992       Impact factor: 2.584

Review 10.  Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.

Authors:  Mark R Green; Stephen L George; Richard L Schilsky
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.